Scientists have discovered the signals that determine the fate of immature cells in the pancreas. The research shows that they
Continue reading »
Anti-CD47 cancer therapy safe, shows promise in small clinical trial
A novel immunotherapy appears safe for use in patients with a type of blood cancer called non-Hodgkin’s lymphoma, according to
Continue reading »Novel combination therapy promotes wound healing
By incorporating a gene-suppressing drug into an over-the-counter gel, researchers at Albert Einstein College of Medicine and their colleagues cut
Continue reading »Is the next big step in cancer therapy personalized vaccines?
Tamara Strauss has been living with high-grade, stage IV pancreatic neuroendocrine cancer for more than three years. Current treatments, although
Continue reading »Research shows at-risk elementary students benefit from child-centered play therapy
Elementary school students who received child-centered play therapy services over the course of a school year showed significant positive changes,
Continue reading »Resistance to therapy and tumor relapse attributed to specific cancer cell population
Resistance to therapy is a major problem in cancer patients, as resistant cells are at the root of tumour relapse
Continue reading »Insomnia therapy may slow or reverse cortical gray matter atrophy in fibromyalgia
Preliminary findings from a pilot study suggest that cognitive behavioral therapy for insomnia (CBT-I) may slow or even reverse the
Continue reading »Celebrity doc disciplined for controversial menopause therapy
Celebrity doctor to Cindy Crawford, Suzanne Somers, and Fergie is disciplined by California medical board over controversial menopause therapy Dr
Continue reading »New HIV therapy reduces virus, boosts immunity in drug-resistant patients
In a study, a new HIV drug reduced viral replication and increased immune cells in individuals with advanced, drug-resistant HIV
Continue reading »Sulfonylureas as 2nd-line T2DM therapy tied to higher event risk
(HealthDay)—Sulfonylureas as second-line drugs for type 2 diabetes are associated with an increased risk of cardiovascular and hypoglycemic events compared
Continue reading »